Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,115.5
-10.6 (-0.34%)

 

  • STI Straits Times Index
    3,115.5
    -10.6 (-0.34%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.7
    -5.8 (-0.37%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,673.0
    -175.5 (-0.65%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,938.1
    -39.2 (-1.32%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,192.3
    11.3 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 702.1M
  • Value: 541.8M
  • Rise: 83
  • Fall: 155
  • Unch: 594

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.001-0.001
Rex Intl0.090+0.002
ThaiBev0.910+0.035
Spackman0.015-0.001
Genting Sing0.915-0.010
KLW0.003-
YZJ Shipbldg SGD0.945-0.005
AEM1.270+0.010
Y Ventures0.113+0.002
NetLink NBN Tr0.910-

World Indices

World Indices
Name Last Change
Nasdaq 8,156.9 +32.7
HSI 26,699.5 -149.0
HSCEI 10,528.6 -59.5
Jakarta 6,191.3 +10.3
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

PALATIN TECHNOLOGIES INC PALATIN TECHNOLOGIES
Updated on 17 Oct 2019 (End of trading day)
Last (USD): 0.835 Change: -0.004 High: 0.844 Remarks: -
Change (%): -0.54 Low: 0.810
Open 0.844 Yesterday's Close 0.8394999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 712,919 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.23411 Trailing EPS (USD) e 0.23411 NAV (USD) b 0.6580
PE a 3.567 Trailing PE f 3.567 Price / NAV b 1.2690
Dividend (USD) d - Cash In Hand (USD) g 0.2848 Issued & Paid-up Shares c 227,039,000
Dividend Yield (%) d - Price / Cash In Hand g 2.932 Treasury Shares h -
Beta - 75 Daysi 1.626 R-Squared - 75 Days(%)i 7.76 Market Cap (M) 127.590
Beta - 500 Daysi 0.708 R-Squared - 500 Days (%)i 2.17 Enterprise Value (M) 84.413
Piotroski F Score 5 Exchange Code PTN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 57.71 Free Float (%) 93.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Sep 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PALATIN TECHNOLOGIES INC NYSE American 127.590 3.567 3.567 1.2690 -
Industry Biotechnology NYSE American 74.130 - - 2.6051 -
Local Peer 22ND CENTURY GROUP INC NYSE American 205.520 - - 3.2982 -
Local Peer PFENEX INC NYSE American 209.408 - - 4.0418 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 143.657 - 4.626 1.0770 -
Local Peer NAVIDEA BIOPHARMACEUTICALS INC NYSE American 129.766 - - 57.1429 -
Local Peer NANOVIRICIDES INC NYSE American 128.099 - - 12.0893 -
Local Peer CEL-SCI CORP NYSE American 77.582 - - 67.6710 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 63.921 - - 2.0752 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 51.029 - - 10.0227 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 41.623 - - 1.8393 -
Local Peer IBIO INC NYSE American 46.103 - - 18.7434 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 30.572 - - 0.9430 -
Local Peer ORAGENICS INC NYSE American 21.976 - - 1.2270 -
Other Local Peers ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), AIM IMMUNOTECH INC (NYSE American)
Global Peer AMGEN INC NASDAQ 122,075.136 14.543 15.340 11.3095 2.723
Global Peer GILEAD SCIENCES INC NASDAQ 82,610.534 15.144 13.872 3.6527 3.538
Global Peer CSL ASX 114,640.245 42.730 42.730 15.3198 1.051
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CELGENE CORP NASDAQ 72,149.834 17.832 13.688 7.1784 -
Global Peer ILLUMINA INC NASDAQ 45,650.850 55.267 48.668 10.5380 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 45,680.260 21.790 20.623 9.0100 -
Global Peer BIOGEN INC NASDAQ 41,611.243 9.392 7.860 3.2125 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,140.839 13.558 16.016 3.3970 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,185.343 73.371 21.628 4.8842 0.817
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), GENSCRIPT BIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), GENOMIC HEALTH INC (NASDAQ), NATERA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 10X GENOMICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), FRONTAGE (HKEx), MOMENTA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), POLYNOVO LIMITED (ASX), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIVA BIOTECH (HKEx), ANAPTYSBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HAOHAI BIOTEC (HKEx), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), AVITA MEDICAL LTD (ASX), KODIAK SCIENCES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VANDA PHARMACE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), ROCKET PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), ARVINAS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ASCLETIS-B (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESSEX BIO-TECH (HKEx), CKLIFE SCIENCES (HKEx), FREQUENCY THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BELLUS HEALTH INC (NASDAQ), PERSONALIS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), IMMUNOGEN INC (NASDAQ), XBIOTECH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), DYNAVAX TECHNOLOGIES CORP (NASDAQ), LEE'S PHARM (HKEx), PRECISION BIOSCIENCES INC (NASDAQ), NEXT SCIENCE LTD (ASX), PROTHENA CORP PLC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), DERMIRA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), AVID BIOSERVICES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), TELIX PHARMACEUTIC (ASX), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), COMPUGEN (NASDAQ), RESTORBIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), GALECTIN THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AFFIMED N V (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), RESAPP HEALTH LIMITED (ASX), CLOVIS ONCOLOGY INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BBI LIFE SCI (HKEx), MINERVA NEUROSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), XOMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ENZO BIOCHEM INC (NYSE), PIERIS PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), X4 PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMV INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PHYLOGICA LIMITED (ASX), APTOSE BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), IMMUTEP LTD (ASX), CURIS INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PORT (SET), NEON THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), IMUGENE LIMITED (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), NEWLINK GENETICS CORP (NASDAQ), ORTHOCELL LIMITED (ASX), VASCULAR BIOGENICS LTD (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), VERMILLION INC (NASDAQ), EVOGENE LTD (NASDAQ), BIONOMICS LTD (ASX), IVERIC BIO INC (NASDAQ), INMUNE BIO INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), BIONANO GENOMICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), BIOTRON (ASX), MIRAGEN THERAPEUTICS INC (NASDAQ), RHINOMED LIMITED (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), SEELOS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), BIOSINO BIO-TEC (HKEx), SENESTECH INC (NASDAQ), EXTRAWELL PHAR (HKEx), SIERRA ONCOLOGY INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), SOLIGENIX INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), SOPHIRIS BIO INC (NASDAQ), BIOCEPT INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), TOCAGEN INC (NASDAQ), ADALTA LTD (ASX), VAXART INC (NASDAQ), IMMURON LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), REGENEUS LTD (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), HEAT BIOLOGICS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), DARE BIOSCIENCE INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CELLMID LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), CAPRICOR THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MGRC (Bursa), XENETIC BIOSCIENCES INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TROVAGENE INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), MEGASUN (Bursa), PHIO PHARMACEUTICALS CORP (NASDAQ), TBG DIAGNOSTICS LTD (ASX), PROTEON THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ), QT Vascular (SGX), CCP TECHNOLOGIES LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), NANOLLOSE LTD (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.009
+1.09 %
10 Days --0.049
-5.54 %
20 Days --0.104
-11.08 %
Medium Term Return 3 Months --0.163
-16.33 %
6 Months --0.225
-21.23 %
1 Year --0.060
-6.70 %
Long Term Return 2 Years -+0.015
+1.83 %
3 Years -+0.292
+53.78 %
5 Years -+0.220
+35.77 %
Annualised Return Annualised --
+6.31 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.590 - 1.780 Change From 1 Year Low +0.245 % Change From 1 Year Low (%) +41.53
Change From 1 Year High -0.945 % Change From 1 Year High (%) -53.09
2 Years Range 0.590 - 1.780 Change From 2 Years Low +0.245 % Change From 2 Years Low (%) +41.53
Change From 2 Years High -0.945 % Change From 2 Years High (%) -53.09
5 Years Range 0.285 - 1.780 Change From 5 Years Low +0.550 % Change From 5 Years Low (%) +192.88
Change From 5 Years High -0.945 % Change From 5 Years High (%) -53.09
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Oct 2019 0.844 0.844 0.810 0.835 712,919 -
16 Oct 2019 0.810 0.858 0.810 0.840 692,896 -
15 Oct 2019 0.821 0.840 0.805 0.840 368,524 -
14 Oct 2019 0.826 0.830 0.810 0.818 365,176 -
11 Oct 2019 0.840 0.852 0.820 0.826 772,450 -
10 Oct 2019 0.830 0.840 0.815 0.816 732,925 -
09 Oct 2019 0.867 0.880 0.804 0.830 1,231,500 -
08 Oct 2019 0.880 0.887 0.850 0.851 801,327 -
07 Oct 2019 0.900 0.900 0.860 0.863 514,951 -
04 Oct 2019 0.880 0.920 0.851 0.884 723,623 -
03 Oct 2019 0.870 0.890 0.850 0.886 2,193,913 -
02 Oct 2019 0.890 0.890 0.852 0.868 903,309 -
01 Oct 2019 0.940 0.940 0.875 0.876 997,357 -
30 Sep 2019 0.900 0.945 0.885 0.909 1,430,453 -
27 Sep 2019 0.870 0.910 0.860 0.887 1,161,274 -
26 Sep 2019 0.905 0.940 0.850 0.868 1,126,301 -
25 Sep 2019 0.893 0.910 0.875 0.895 1,018,538 -
24 Sep 2019 0.910 0.919 0.889 0.894 1,211,906 -
23 Sep 2019 0.950 0.950 0.915 0.915 989,717 -
20 Sep 2019 0.938 0.976 0.934 0.939 1,365,908 -
19 Sep 2019 0.970 0.989 0.937 0.937 1,120,610 -
18 Sep 2019 1.020 1.030 0.940 0.947 2,449,380 -
Summary
Current 2 Weeks
(04 Oct 2019 to 17 Oct 2019)		 0.880 0.920 0.804 0.835 6,916,291 -
Previous 2 Weeks
(20 Sep 2019 to 03 Oct 2019)		 0.938 0.976 0.804 0.886 12,398,676 -
4 Weeks from
(22 Aug 2019 to 19 Sep 2019)		 0.910 0.936 0.804 0.937 28,412,651 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.